News Archive - Alumni

Scientists Identify Climate Change as Major Contributor to Record-Breaking Marine Heatwave

Two new studies led by scientists at Scripps Institution of Oceanography at the University of California San Diego highlight the significance of long-term observations for understanding ocean climate trends and events, including record-shattering marine heatwaves.

Mobile Life Support Delivered to Area Hospitals During COVID-19 Pandemic

UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.

Public Disclosure of COVID-19 Cases Is More Effective than Lockdowns

South Korea is a standout in the current battle against COVID-19, largely due to its widespread testing and contact tracing; however, key to its innovation is publicly disclosing detailed information on the individuals who test positive for COVID-19.

QS World University Rankings Name UC San Diego Nation’s 6th Best Public University

The University of California San Diego has been named the nation’s sixth best public university by QS World University Rankings, which released their inaugural list of America’s top universities based on diversity, employability and internationalization on May 20. The first annual QS World Universit

RNA Molecules in Maternal Blood May Predict Pregnancies at Risk for Preeclampsia

UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.

Supercomputers Reveal True Strengths of Some Zirconia Ceramics

Researchers from the Colorado School of Mines have been using multiple supercomputers, including SDSC's Comet system, to study certain characteristics of zirconia for wider applications of the super-strong material.

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.